Mexico Cancer Research
International Collaboration Leader & Cervical Cancer Pioneer
Cervical Cancer Reduction
20-year breakthrough study
CAR-T in Latin America
Pilot programs launched
Screening Rate Increase
Breast cancer awareness
20-Year Cervical Cancer Clinical Trial Breakthrough
Mexico completed a landmark 20-year clinical trial proving HPV vaccination combined with screening reduces cervical cancer incidence by 90%+. This study influences global policy.
Impact:
Shaping global cervical cancer prevention strategies
CAR-T Therapy Pilot Programs
Mexico launched Latin America's first CAR-T therapy pilot programs in partnership with US institutions, bringing advanced immunotherapy to Mexican patients at lower costs.
Impact:
Democratizing CAR-T access in Mexico
US NCI-Funded Cancer Research Programs
Mexico partners with the US National Cancer Institute on cross-border research studying cancer genetics in Hispanic/Latino populations.
Impact:
Improving cancer care for 60+ million Hispanic Americans
Affordable Generic Drug Production
Mexico manufactures high-quality generic cancer drugs for North and Latin America, reducing treatment costs by 70%+.
Impact:
Making cancer treatment affordable across the Americas
Telemedicine Oncology Network
Mexico built a nationwide telemedicine network connecting rural patients to oncology specialists in Mexico City, serving millions in underserved areas.
Impact:
Eliminating geographic barriers to cancer care
Breast Cancer Awareness & Early Detection Campaigns
Mexico's massive public health campaigns increased breast cancer screening rates by 200% in 10 years, saving thousands of lives annually.
Impact:
Catching breast cancer earlier when it's most curable
Instituto Nacional de Cancerología (INCan)
Mexico City
Mexico's premier cancer institute. Leading research in cervical, breast, and pediatric cancers. Strong partnerships with US NCI and international organizations.
Key Specialties:
Centro Médico Nacional Siglo XXI
Mexico City
Major public hospital conducting cancer research for Mexico's social security system. Focus on accessible, affordable cancer care.
Key Specialties:
Hospital Ángeles Pedregal
Mexico City
Private hospital pioneering CAR-T therapy and advanced immunotherapy in Mexico. International partnerships for clinical trials.
Key Specialties:
Mexico welcomes international patients to cutting-edge clinical trials
CAR-T for Leukemia (Mexico-US Partnership)
Testing CAR-T cell therapy for pediatric and adult leukemia patients in partnership with US cancer centers.
HPV Vaccination Long-term Efficacy Study
Ongoing 20+ year study tracking HPV vaccination outcomes and cervical cancer prevention in vaccinated cohorts.
Breast Cancer Precision Medicine
Tailoring breast cancer treatments based on genetic testing for Mexican women with BRCA and other mutations.
